<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11859417</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1539</article-id><article-id pub-id-type="other">EPV0948</article-id><article-id pub-id-type="pii">S0924933824015396</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>&#x0201c;God speaks to me through a dove&#x0201d;. The evidence of clozapine in treatment-refractory psychosis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rodr&#x000ed;guez Rodr&#x000ed;guez</surname><given-names>B.</given-names></name><xref rid="aff3363" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Marqu&#x000e9;s Cabezas</surname><given-names>P.</given-names></name><xref rid="aff3363" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor1388" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Queipo de Llano de La Viuda</surname><given-names>M.</given-names></name><xref rid="aff3363" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Navarro Barriga</surname><given-names>N.</given-names></name><xref rid="aff3363" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Guerra Valera</surname><given-names>G.</given-names></name><xref rid="aff3363" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Arribas Sim&#x000f3;n</surname><given-names>M. B.</given-names></name><xref rid="aff3363" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Alario Ruiz</surname><given-names>C.</given-names></name><xref rid="aff3363" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Mateos Sexmero</surname><given-names>M. J.</given-names></name><xref rid="aff3363" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Fern&#x000e1;ndez Lozano</surname><given-names>M.</given-names></name><xref rid="aff3363" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Mar&#x000ed;nez Gimeno</surname><given-names>P.</given-names></name><xref rid="aff3363" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Calvo Valc&#x000e1;rcel</surname><given-names>M.</given-names></name><xref rid="aff3363" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Andreo Vidal</surname><given-names>M. A.</given-names></name><xref rid="aff3363" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Pando Fern&#x000e1;ndez</surname><given-names>M. P.</given-names></name><xref rid="aff3363" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Monllor Lazarraga</surname><given-names>A.</given-names></name><xref rid="aff3363" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>R&#x000ed;os Vaquero</surname><given-names>M.</given-names></name><xref rid="aff3363" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lorenzo Chapate</surname><given-names>G.</given-names></name><xref rid="aff3363" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Rojas V&#x000e1;zquez</surname><given-names>L.</given-names></name><xref rid="aff3363" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>De Andr&#x000e9;s Lobo</surname><given-names>C.</given-names></name><xref rid="aff3363" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Jim&#x000e9;nez Aparicio</surname><given-names>T.</given-names></name><xref rid="aff3364" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Vallecillo Adame</surname><given-names>M. D. C.</given-names></name><xref rid="aff3363" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff3363"><sup>1</sup>Psiquiatr&#x000ed;a, <institution>Hospital Cl&#x000ed;nico Universitario de Valladolid</institution>, <city>Valladolid</city></aff><aff id="aff3364"><sup>2</sup>Psiquiatr&#x000ed;a, <institution>Hospital Cl&#x000ed;nico Universitario de Valladolid</institution>, <city>Valladolid&#x000ba;</city>, <country>Spain</country></aff><author-notes><corresp id="cor1388"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="1514">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S740</fpage><lpage>S740</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824015396a.pdf"/><abstract><sec id="sec8344"><title>Introduction</title><p>Clozapine is an atypical antipsychotic synthesised in 1958. It was withdrawn from the market in the 1970s due to the appearance of agranulocytosis, but was reintroduced due to strong evidence of its efficacy and superiority over other antipsychotics in treatment-resistant schizophrenia.</p></sec><sec id="sec8345"><title>Objectives</title><p>To describe the adequate response to clozapine in treatment-refractory psychosis.</p></sec><sec id="sec8346"><title>Methods</title><p>Review of the scientific literature based on a relevant clinical case.</p></sec><sec id="sec8347"><title>Results</title><p>A 16-year-old woman was admitted to a psychiatric inpatient unit for psychotic symptoms and behavioural disorders. She lives with her father and older sister; she has not been in contact with her mother, who lives in another country, for several years. She attends secondary school, with poor academic performance. Maternal diagnosis of schizophrenia. She started using cannabis two years ago, with a progressive increase up to 20 grams per week. He reports the onset of a feeling of strangeness a year ago, with progressive isolation in his room, referring to delirious ideation of harm towards classmates and people from his town, self-referentiality and delirious interpretations of religious mystical content (&#x0201c;God speaks to me through a dove&#x0201d;).&#x000a0;He comments on the phenomenon of theft and thought-reading. Soliloquies and unmotivated laughter are observed.</p></sec><sec id="sec8348"><title>Conclusions</title><p>Treatment was started with risperidone, progressively increasing the dose up to optimisation, without achieving a decrease in positive symptoms, but with the appearance of excessive sedation and sialorrhoea. It was combined with aripiprazole up to 20mg, maintained for a couple of weeks, without significant clinical improvement. Given the failure of two lines of therapy, it was decided to change to clozapine up to a dose of 75mg, with adequate tolerance and response, achieving a distancing of the delirious ideation. Regular haematological controls were performed, with no alterations in haemogram or troponins.</p></sec><sec id="sec8349"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>